Main Article Content
METHYLPHENIDATE FORMULATIONS, ADHD
This issue’s article by Margaret Steele et al1 reports the results from a clinical trial comparing the effectiveness of a long acting methylphenidate formulation, OROS- methylphenidate (OROS-MPH), with immediate release methylphenidate (IR-MPH).
2. Swanson J. Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement. CNS Drugs.2003;17(2): 117-31.
3. Sanchez RJ, Crimson ML, Barner JC, Bettinger T, Wilson JP. Assessment of adherence measures with different stimulants among children and
adolescents. Pharmacotherapy. 2005 Jul; 25(7):909-17.
4. Marcus SC, Wan GJ, Kemner JE, Olfson M. Continuity of methylphenidate treatment for attention deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2005 Jun; 159(6): 572-8.
5. Dosreis S, ZitoJM, Safer DJ, et al. Parental perceptions and satisfaction with stimulant medication for attention deficit/hyperactivity disorder. J Dev Behav Pediatr. 2003 Jun;24(3): 155-62.